BlackRock Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $103K | Buy |
13,313
+2,168
| +19% | +$16.8K | ﹤0.01% | 2954 |
|
|
2016
Q3 | $127K | Sell |
11,145
-7,171
| -39% | -$81.7K | ﹤0.01% | 2849 |
|
|
2016
Q2 | $225K | Buy |
18,316
+3,936
| +27% | +$48.4K | ﹤0.01% | 2495 |
|
|
2016
Q1 | $146K | Buy |
14,380
+7,400
| +106% | +$75.1K | ﹤0.01% | 2673 |
|
|
2015
Q4 | $157K | Sell |
6,980
-3,302
| -32% | -$74.3K | ﹤0.01% | 2661 |
|
|
2015
Q3 | $171K | Buy |
10,282
+223
| +2% | +$3.71K | ﹤0.01% | 2774 |
|
|
2015
Q2 | $226K | Buy |
10,059
+3,232
| +47% | +$72.6K | ﹤0.01% | 2692 |
|
|
2015
Q1 | $176K | Sell |
6,827
-18,353
| -73% | -$473K | ﹤0.01% | 2723 |
|
|
2014
Q4 | $548K | Buy |
25,180
+19,924
| +379% | +$434K | ﹤0.01% | 1908 |
|
|
2014
Q3 | $99K | Sell |
5,256
-5,842
| -53% | -$110K | ﹤0.01% | 2976 |
|
|
2014
Q2 | $259K | Buy |
11,098
+7,607
| +218% | +$178K | ﹤0.01% | 2441 |
|
|
2014
Q1 | $117K | Sell |
3,491
-6,462
| -65% | -$217K | ﹤0.01% | 2938 |
|
|
2013
Q4 | $294K | Buy |
9,953
+2,154
| +28% | +$63.6K | ﹤0.01% | 2392 |
|
|
2013
Q3 | $119K | Buy |
+7,799
| New | +$119K | ﹤0.01% | 2846 |
|